ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
12 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
Wilba32
|
199 |
71K |
3 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
199
|
71K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Wilba32
|
501 |
170K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
501
|
170K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Wilba32
|
501 |
170K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
501
|
170K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
Wilba32
|
199 |
71K |
8 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
199
|
71K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
30 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
30
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Wilba32
|
339 |
116K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
339
|
116K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
8 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Wilba32
|
339 |
116K |
36 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
339
|
116K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.4K |
2.7M |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
10 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
4 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
4 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
10 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
8 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
9.0K |
3.4M |
3 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
9.0K
|
3.4M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
9.0K |
3.4M |
2 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
9.0K
|
3.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
3 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
225
|
81K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
5 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
225
|
81K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
8 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
225
|
81K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
5 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
15 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
6 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
17 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
8 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.4K |
2.7M |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.4K |
2.7M |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
15 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
9 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
17 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
14 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
6 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
dividend
|
|
Wilba32
|
8 |
3.0K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
8
|
3.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
10K |
3.0M |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
9 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
81K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.4K |
2.7M |
18 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
9 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
423K |
11 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
5 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
81K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
2 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
81K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
15 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
81K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
5 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
81K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
33 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
81K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
225 |
81K |
9 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
81K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
6 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|